The Biostatistics and Data Management Core will provide the statistical, systems and data management support for research conducted within the scope of SPOTRIAS projects. This will include collaboration and consultation on the statistical aspects of study design and planning, electronic data capture (EDC) system development and maintenance, data quality control and study monitoring as well as data analysis and interpretation. The Core will ensure adherence to the highest standards of good statistical and data management practice.
The specific aims of this Core are: 1. To provide statistical and computational expertise for the design, planning, conduct, analysis, and reporting of laboratory experiments, imaging studies, observational studies, and clinical trials associated with the Partners based SPOTRIAS Projects. 2. To provide ready access to statistical and computational expertise to the entire group of SPOTRIAS investigators through "open door" consultation. 3. To advise and support SPOTRIAS investigators in the areas of electronic case report forms (eCRFs) design, data collection, electronic data capture and data management system (ECD&DM) design and development, and data quality control. 4. To collaborate with Biostatisticians on provision of reports to study principal investigators, medical monitor, and the Data Safety and Monitoring Board (DSMB).

Public Health Relevance

The main functions of the Biostatistics and Data Management Core are to provide short-term and long-term consultation and collaboration on the design and analysis of the proposed projects. The Core will also provide services on all matters of data capture and management, including CRF creation, EDC&DM system design, methods for data quality control, statistical computer packages, and publicly available software.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS051343-09
Application #
8484461
Study Section
Special Emphasis Panel (ZNS1-SRB-R)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
9
Fiscal Year
2013
Total Cost
$141,113
Indirect Cost
$46,549
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Matsouaka, Roland A; Betensky, Rebecca A (2015) Power and sample size calculations for the Wilcoxon-Mann-Whitney test in the presence of death-censored observations. Stat Med 34:406-31
Brouwers, H Bart; Raffeld, Miriam R; van Nieuwenhuizen, Koen M et al. (2014) CT angiography spot sign in intracerebral hemorrhage predicts active bleeding during surgery. Neurology 83:883-9
Brouwers, H Bart; Chang, Yuchiao; Falcone, Guido J et al. (2014) Predicting hematoma expansion after primary intracerebral hemorrhage. JAMA Neurol 71:158-64
Radmanesh, Farid; Devan, William J; Anderson, Christopher D et al. (2014) Accuracy of imputation to infer unobserved APOE epsilon alleles in genome-wide genotyping data. Eur J Hum Genet 22:1239-42
Boulouis, Grégoire; Dumas, Andrew; Betensky, Rebecca A et al. (2014) Anatomic pattern of intracerebral hemorrhage expansion: relation to CT angiography spot sign and hematoma center. Stroke 45:1154-6
Kimberly, W Taylor; Battey, Thomas W K; Pham, Ly et al. (2014) Glyburide is associated with attenuated vasogenic edema in stroke patients. Neurocrit Care 20:193-201
Ruff, Ilana M; Ali, Syed F; Goldstein, Joshua N et al. (2014) Improving door-to-needle times: a single center validation of the target stroke hypothesis. Stroke 45:504-8
Boltze, Johannes; Ayata, Cenk; Wagner, Daniel-Christoph et al. (2014) Preclinical phase III trials in translational stroke research: call for collective design of framework and guidelines. Stroke 45:357
Mormino, Elizabeth C; Betensky, Rebecca A; Hedden, Trey et al. (2014) Amyloid and APOE ?4 interact to influence short-term decline in preclinical Alzheimer disease. Neurology 82:1760-7
Opherk, Christian; Gonik, Mariya; Duering, Marco et al. (2014) Genome-wide genotyping demonstrates a polygenic risk score associated with white matter hyperintensity volume in CADASIL. Stroke 45:968-72

Showing the most recent 10 out of 73 publications